FI890907A0 - Kymotrypsiinin käyttö prekallikreiini-aktivaattorin tehottamiseksi tekemiseksi - Google Patents
Kymotrypsiinin käyttö prekallikreiini-aktivaattorin tehottamiseksi tekemiseksiInfo
- Publication number
- FI890907A0 FI890907A0 FI890907A FI890907A FI890907A0 FI 890907 A0 FI890907 A0 FI 890907A0 FI 890907 A FI890907 A FI 890907A FI 890907 A FI890907 A FI 890907A FI 890907 A0 FI890907 A0 FI 890907A0
- Authority
- FI
- Finland
- Prior art keywords
- chymotrypsin
- preparations
- disable
- immobilised
- activator
- Prior art date
Links
- 108090000317 Chymotrypsin Proteins 0.000 title abstract 6
- 229960002376 chymotrypsin Drugs 0.000 title abstract 6
- 239000012190 activator Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 abstract 4
- 102000009027 Albumins Human genes 0.000 abstract 1
- 108010088751 Albumins Proteins 0.000 abstract 1
- 108010017384 Blood Proteins Proteins 0.000 abstract 1
- 102000004506 Blood Proteins Human genes 0.000 abstract 1
- 108010071241 Factor XIIa Proteins 0.000 abstract 1
- 239000010836 blood and blood product Substances 0.000 abstract 1
- 229940125691 blood product Drugs 0.000 abstract 1
- 238000005194 fractionation Methods 0.000 abstract 1
- 229940027941 immunoglobulin g Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000007086 side reaction Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y10S530/83—Plasma; serum
- Y10S530/831—Cohn fractions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0049488A AT391810B (de) | 1988-02-26 | 1988-02-26 | Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators |
| AT49488 | 1988-02-26 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI890907A0 true FI890907A0 (fi) | 1989-02-24 |
| FI890907L FI890907L (fi) | 1989-08-27 |
| FI93696B FI93696B (fi) | 1995-02-15 |
| FI93696C FI93696C (fi) | 1995-05-26 |
Family
ID=3492093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI890907A FI93696C (fi) | 1988-02-26 | 1989-02-24 | Kymotrypsiinin käyttö prekallikreiini-aktivaattorin tehottamiseksi tekemiseksi |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US5094949A (fi) |
| EP (1) | EP0330647B1 (fi) |
| JP (1) | JPH07116052B2 (fi) |
| AT (2) | AT391810B (fi) |
| CA (1) | CA1338499C (fi) |
| DE (1) | DE58905495D1 (fi) |
| DK (1) | DK90589A (fi) |
| ES (1) | ES2059826T3 (fi) |
| FI (1) | FI93696C (fi) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT391810B (de) * | 1988-02-26 | 1990-12-10 | Immuno Ag | Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators |
| JP4532282B2 (ja) * | 2002-11-25 | 2010-08-25 | オクタファルマ アクチェン ゲゼルシャフト | 低プレカリクレイン血漿由来アルブミン画分 |
| ES2221817B1 (es) | 2004-07-26 | 2005-10-01 | Probitas Pharma, S.A. | "soluciones de albumina humana terapeutica con baja actividad del activador de precalicreina (pka) y procedimiento de obtencion de las mismas". |
| FR2895263B1 (fr) | 2005-12-26 | 2008-05-30 | Lab Francais Du Fractionnement | Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU469815B2 (en) * | 1971-04-14 | 1973-10-18 | Anti-inflammatory compositions | |
| DE2835843A1 (de) * | 1978-08-16 | 1980-02-28 | Blutspendedienst Dt Rote Kreuz | Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten gammaglobulinloesung |
| US4272521A (en) * | 1979-07-16 | 1981-06-09 | Cutter Laboratories, Inc. | Purified immune serum globulin |
| US4251510A (en) * | 1979-08-15 | 1981-02-17 | Cutter Laboratories, Inc. | Intravenously injectable solution of plasma protein fraction free from bradykinin, kininogen and prekallikrein activators and processes for its production |
| CH664496A5 (de) * | 1982-05-31 | 1988-03-15 | Mochida Pharm Co Ltd | Material zur entfernung von immunkomplexen aus dem blut oder aus plasma. |
| AT376367B (de) * | 1983-03-16 | 1984-11-12 | Immuno Ag | Verfahren zur herstellung von therapeutisch verabreichbaren, in endbehaeltern abgefuellten plasmaderivaten |
| AT383739B (de) * | 1983-03-16 | 1987-08-10 | Immuno Ag | Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen in immunglobulinhaeltigen blutfraktionen |
| AT390560B (de) * | 1986-05-30 | 1990-05-25 | Immuno Ag | Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern |
| AT391810B (de) * | 1988-02-26 | 1990-12-10 | Immuno Ag | Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators |
-
1988
- 1988-02-26 AT AT0049488A patent/AT391810B/de not_active IP Right Cessation
-
1989
- 1989-02-20 DE DE89890044T patent/DE58905495D1/de not_active Expired - Fee Related
- 1989-02-20 EP EP89890044A patent/EP0330647B1/de not_active Expired - Lifetime
- 1989-02-20 ES ES89890044T patent/ES2059826T3/es not_active Expired - Lifetime
- 1989-02-20 AT AT89890044T patent/ATE94071T1/de not_active IP Right Cessation
- 1989-02-22 CA CA000591730A patent/CA1338499C/en not_active Expired - Fee Related
- 1989-02-23 JP JP1045037A patent/JPH07116052B2/ja not_active Expired - Lifetime
- 1989-02-24 FI FI890907A patent/FI93696C/fi not_active IP Right Cessation
- 1989-02-24 US US07/315,163 patent/US5094949A/en not_active Expired - Fee Related
- 1989-02-24 DK DK090589A patent/DK90589A/da unknown
-
1991
- 1991-10-15 US US07/775,587 patent/US5324628A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0330647A3 (en) | 1990-05-09 |
| AT391810B (de) | 1990-12-10 |
| ATA49488A (de) | 1990-06-15 |
| US5324628A (en) | 1994-06-28 |
| DK90589A (da) | 1989-08-27 |
| CA1338499C (en) | 1996-07-30 |
| EP0330647A2 (de) | 1989-08-30 |
| US5094949A (en) | 1992-03-10 |
| EP0330647B1 (de) | 1993-09-08 |
| JPH01261332A (ja) | 1989-10-18 |
| JPH07116052B2 (ja) | 1995-12-13 |
| FI93696B (fi) | 1995-02-15 |
| DK90589D0 (da) | 1989-02-24 |
| DE58905495D1 (de) | 1993-10-14 |
| ES2059826T3 (es) | 1994-11-16 |
| FI890907L (fi) | 1989-08-27 |
| FI93696C (fi) | 1995-05-26 |
| ATE94071T1 (de) | 1993-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE138575T1 (de) | Verfahren zur inaktivierung von viren in mit viren verunreinigten pharmazeutischen zusammensetzungen | |
| AU578050B2 (en) | Desulfatohirudins, the preparation thereof and pharmaceutical compositions containing them | |
| ATE104348T1 (de) | O-glycosyliertes ifn-alpha. | |
| DE69008664D1 (de) | Bestrahlung von bluterzeugnissen. | |
| DK614987A (da) | Syntetiske htlv-iii peptider, praeparater og anvendelser deraf | |
| DE69000248D1 (de) | Verwendung von interzellularen adhaesions-molekuelen und deren bindungsliganden bei der behandlung von asthma. | |
| DE69005959D1 (de) | Verfahren zur Reinigung von menschlichem Serum-Albumin. | |
| ATE54826T1 (de) | Thymusextraktfraktionen enthaltende pharmazeutische zusammensetzung. | |
| ES2080047T3 (es) | Peptidos hiv y metodos para la deteccion de hiv. | |
| FI93696B (fi) | Kymotrypsiinin käyttö prekallikreiini-aktivaattorin tehottamiseksi tekemiseksi | |
| DE69837824D1 (de) | Löslicher Natamycin-Proteinkomplex | |
| MX9301858A (es) | Anticuerpos monoclonales neutralizantes de hiv-humano recombinante para prevencion y tratamiento de infeccion hiv. | |
| DE58906510D1 (de) | Immunogen und seine Verwendung zur Gewinnung von Antikörpern gegen Hämoglobin A1C. | |
| DK3689A (da) | Fremgangsmaade til inaktivering af formeringsdygtige, filtrerbare sygdomsvaekkere i blodplasmaprodukter | |
| DE3750886D1 (de) | Verwendung eines immunglobulinhaltigen Präparates zur Prophylaxe und Therapie von AIDS beim Menschen. | |
| ATE194648T1 (de) | Verfahren zur inaktivierung von viren in präparationen von proteinen | |
| DK131284A (da) | Fremgangsmaade til inaktivering af stoffer, der foraarsager uforenelighedsreaktioner | |
| DK0445626T3 (da) | Funktionel test til bestemmelse af protein S-aktivitet. | |
| NO179127C (no) | Fremgangsmåte for pasteurisering av blodplasma samt blanding for utförelse derav | |
| FI885025A0 (fi) | Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning. | |
| DE3766258D1 (de) | Spiegelndes produkt von goldener faerbung und verfahren zu dessen herstellung. | |
| DE69631528D1 (de) | Serumzusammensetzungen zur hemmung von retroviren und tumorwachstum | |
| ATE46520T1 (de) | Verfahren zur herstellung von steroiden, insbesondere von zwischenprodukten in der herstellung von proligeston und verwandte zwischenprodukte und neue erhaltene zwischenprodukte. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application | ||
| MM | Patent lapsed |
Owner name: IMMUNO AKTIENGESELLSCHAFT |